MADISON ROGOWSKI: Open Payments
NPI 1306537634 · GRANDVIEW, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,301 in 81 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $916 · 2025 $1,301
Food & beverage: $1,301
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $274 |
| PFIZER INC. | 14 | $153 |
| Amgen Inc. | 11 | $144 |
| Novo Nordisk Inc | 9 | $144 |
| ABBVIE INC. | 6 | $120 |
| Lilly USA, LLC | 8 | $111 |
| Abbott Laboratories | 4 | $78 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| Sumitomo Pharma America, Inc. | 3 | $44 |
| Merck Sharp & Dohme LLC | 2 | $32 |
Products named: AIRSUPRA, NURTEC ODT, Ozempic, FREESTYLE LIBRE 3, REXULTI, BREZTRI, MOUNJARO, KRYSTEXXA.
Industry payments across MO — which companies pay providers there.
